| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.227 | 26.062 | 41.902 | 66.357 | 65.733 |
| Total Income - EUR | - | - | - | - | - | 11.227 | 26.062 | 41.902 | 66.357 | 65.733 |
| Total Expenses - EUR | - | - | - | - | - | 883 | 1.113 | 2.262 | 9.631 | 13.044 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 10.345 | 24.949 | 39.640 | 56.727 | 52.689 |
| Net Profit/Loss - EUR | - | - | - | - | - | 10.026 | 24.168 | 38.663 | 56.162 | 50.756 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ţeighiu Dav-Med Skin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 651 | 1.156 |
| Current Assets | - | - | - | - | - | 10.322 | 33.706 | 58.596 | 88.490 | 85.916 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 6.036 | 26.147 | 26.881 | 1.907 | 36.588 |
| Cash | - | - | - | - | - | 4.286 | 7.559 | 31.715 | 86.583 | 49.328 |
| Shareholders Funds | - | - | - | - | - | 10.067 | 24.216 | 38.711 | 68.159 | 50.805 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 255 | 9.490 | 19.885 | 20.983 | 36.267 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ţeighiu Dav-Med Skin S.r.l.